High risk of obstructive sleep apnea is a risk factor of death censored graft loss in kidney transplant recipients: An observational cohort study

Sleep Medicine

Volumn 12, Issue 3, 2011, Pages 267-273

  Szentkiralyi, Andras ^a   Czira, Maria E ^a   Molnar, Miklos Z ^a,b   Kovesdy, Csaba P ^c,d   Remport, Adam ^e   Szeifert, Lilla ^a   Vamos, Eszter P ^f   Juhasz, Janos ^g   Turanyi, Csilla Z ^a   Mucsi, Istvan ^a,h   Novak, Marta ^a,i  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e Szent Imre Hospital   (Hungary)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g Imtalklinik GMBH   (Germany)

^h MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

ⁱ UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Chronic kidney disease; Gender difference; Graft failure; Kidney transplantation; Mortality; Obstructive sleep apnea syndrome

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DEATH; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SURVIVAL RATE;

ADULT; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; SLEEP APNEA, OBSTRUCTIVE;

EID: 79952191264     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2010.08.012     Document Type: Article

References (43)

1. Redline S., Strohl K.P. Recognition and consequences of obstructive sleep apnea hypopnea syndrome. Clin Chest Med 1998, 19:1-19.
2. Reichmuth K.J., Austin D., Skatrud J.B., Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005, 172:1590-1595.
3. Yaggi H.K., Concato J., Kernan W.N., et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353:2034-2041.
4. Lavie-Nevo K., Pillar G. Evening-morning differences in blood pressure in sleep apnea syndrome: effect of gender. Am J Hypertension 2006, 19:1064-1069.
5. Newman A.B., Foster G., Givelber R., et al. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med 2005, 165:2408-2413.
6. Mehra R., Benjamin E.J., Shahar E., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006, 173:910-916.
7. Kono M., Tatsumi K., Saibara T., et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007, 131:1387-1392.
8. Dunai A., Keszei A.P., Kopp M.S., et al. Cardiovascular disease and health-care utilization in snorers: a population survey. Sleep 2008, 31:411-416.
9. Kuhlmann U., Becker H.F., Birkhahn M., et al. Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol 2000, 53:460-466.
10. Markou N., Kanakaki M., Myrianthefs P., et al. Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 2006, 184:43-49.
11. Chen W.C., Lim P.S., Wu W.C., et al. Sleep behavior disorders in a large cohort of chinese (Taiwanese) patients maintained by long-term hemodialysis. Am J Kidney Dis 2006, 48:277-284.
12. Unruh M.L., Sanders M.H., Redline S., et al. Sleep apnea in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the Sleep Heart Health Study. J Am Soc Nephrol 2006, 17:3503-3509.
13. Zoccali C., Mallamaci F., Tripepi G. Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J Am Soc Nephrol 2002, 13:729-733.
14. Molnar M.Z., Lazar A.S., Lindner A., et al. Sleep apnea is associated with cardiovascular risk factors among kidney transplant patients. Clin J Am Soc Nephrol 2010, 5:125-132.
15. Molnar M.Z., Szentkiralyi A., Lindner A., et al. High prevalence of patients with a high risk for obstructive sleep apnoea syndrome after kidney transplantation - Association with declining renal function. Nephrol Dial Transplant 2007, 22:2686-2692.
16. Diaz-Atauri M.J., Ausin P., Sayas J., et al. Confirming high prevalence of patients with a high risk for obstructive sleep apnoea syndrome after kidney transplantation. Nephrol Dial Transplant 2008, 23:1458-1459. author reply 9.
17. Beecroft J.M., Zaltzman J., Prasad R., et al. Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease. Nephrol Dial Transplant 2007, 22:3028-3033.
18. Mallamaci F., Leonardis D., Tripepi R., et al. Sleep disordered breathing in renal transplant patients. Am J Transplant 2009, 9:1373-1381.
19. de Oliveira Rodrigues C.J., Marson O., Tufic S., et al. Relationship among end-stage renal disease, hypertension, and sleep apnea in nondiabetic dialysis patients. Am J Hypertension 2005, 18:152-157.
20. Jung H.H., Han H., Lee J.H. Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients. Am J Kidney Dis 2005, 45:875-882.
21. Kinebuchi S., Kazama J.J., Satoh M., et al. Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 2004, 107:317-322.
22. Molnar M.Z., Novak M., Szeifert L., et al. Restless legs syndrome, insomnia, and quality of life after renal transplantation. J Psychosom Res 2007, 63:591-597.
23. Molnar M.Z., Szentkiralyi A., Lindner A., et al. Restless Legs Syndrome and mortality in kidney transplant recipients. Am J Kidney Dis 2007, 50:813-820.
24. Molnar M.Z., Czira M., Ambrus C., et al. Anemia is associated with mortality in kidney-transplanted patients - A prospective cohort study. Am J Transplant 2007, 7:818-824.
25. Levey A., Greene T., Kusek J., et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000, 11:155. Abstract.
26. Yarlagadda S.G., Coca S.G., Garg A.X., et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 2008, 23:2995-3003.
27. Craven J., Littlefield C., Rodin G., Murray M. The Endstage Renal Disease Severity Index (ESRD-SI). Psychol Med 1991, 21:237-243.
28. Molnar M.Z., Novak M., Ambrus C., et al. Anemia in kidney transplanted patients. Clin Transplant 2005, 19:825-833.
29. Molnar M.Z., Novak M., Ambrus C., et al. Restless Legs Syndrome in patients after renal transplantation. Am J Kidney Dis 2005, 45:388-396.
30. Mucsi I., Molnar M.Z., Ambrus C., et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant 2005, 20:571-577.
31. Netzer N.C., Stoohs R.A., Netzer C.M., et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999, 131:485-491.
32. Fine J.P., Gray R.J. A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc 1999, 94:496-509.
33. Stehouwer C.D., Nauta J.J., Zeldenrust G.C., et al. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992, 340:319-323.
34. Pedrinelli R., Giampietro O., Carmassi F., et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994, 344:14-18.
35. Clausen P., Feldt-Rasmussen B., Jensen G., Jensen J.S. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clin Sci (Lond) 1999, 97:37-43.
36. Stehouwer C.D., Gall M.A., Twisk J.W., et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002, 51:1157-1165.
37. Faulx M.D., Larkin E.K., Hoit B.D., et al. Sex influences endothelial function in sleep-disordered breathing. Sleep 2004, 27:1113-1120.
38. Suarez E.C. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 2008.
39. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
40. Drager L.F., Genta P.R., Pedrosa R.P., et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 2010, 105:1135-1139.
41. Bazzano L.A., Khan Z., Reynolds K., He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417-423.
42. Drager L.F., Bortolotto L.A., Figueiredo A.C., et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176:706-712.
43. Cross M.D., Mills N.L., Al-Abri M., et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax 2008, 63:578-583.